Market participants are receiving regulatory body approvals for cell culture-based vaccine production, which will accelerate the expansion of the worldwide newborn calf serum market. For instance, the national regulator, the Drugs Controller General of India (DCGI), approved the COVID-19 vaccine known as Covaxin in January 2021. One of the essential components of the media used to cultivate cells for the production of Covaxin is newborn calf serum. The vero cell line, which is utilised to make vaccines, is grown using newborn calf serum.
The coronavirus pandemic is anticipated to fuel the growth of the newborn calf serum market throughout the anticipated time frame. On December 31, 2019, Wuhan, China, became the site of the initial detection of COVID-19, the most current pandemic. The World Health Organization labelled coronavirus disease a pandemic on March 11, 2020. The Weekly Epidemic Update on COVID-19 from the World Health Organization (WHO) shows that fewer new cases have been detected since May 15, 2022. As a result, there were around 6 million fatalities and 518 million documented cases as of May 15, 2022.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5331
Following the COVID-19 pandemic, a rise in the demand for medical devices, diagnostics, and vaccinations prompted several rivals in the life sciences industry to step up their efforts in cell culture research and development. The utilisation of cell culture techniques is growing. To help its biopharmaceutical and contract development and manufacturing organisation (CDMO) clients with the discovery, development, and regulatory filings of their therapeutic biologics, for instance, Avance Biosciences, a leading Contract Research Organization (CRO), announced the expansion of new facilities for mammalian cell culture and protein analysis services on May 5, 2022. With the help of these new facilities, Avance will be able to better meet the demands of its Good Manufacturing Facilities (GMP) clients and focus on providing services for protein- and cell-based assays.
To diversify their portfolios, market players engage in inorganic operations including partnerships with rivals in the life sciences sector. Over the forecast period, this is anticipated to fuel the expansion of the global market for newborn calf serum. For instance, in 2021, the biopharmaceutical startup Nurix Therapeutics announced a partnership with Sanofi, a large healthcare conglomerate, to create novel targeted protein degradation therapies. As part of this partnership, Nurix will make use of its drug discovery platform. In the novel drug discovery, cell culture techniques will be employed to evaluate the efficacy of the pharmacological agent that might increase the utilisation of newborn calf serum.
Over the projected period (2022-2030), the market for newborn calf serum is anticipated to develop at a CAGR of 6.8% due to expansion in promising areas, particularly in Europe. While the largest market share was in North America.
The expansion of the global market for new born calf serum is anticipated to be driven by published scientific reports on the benefits of the product. For instance, foetal calf serum may be replaced by newborn calf serum, which is less expensive and more readily available, according to a July 2018 article in the National Center for Biotechnology Information (NCBI). Newborn calf serum is a highly effective macromolecule when added to in vitro maturation medium, in vitro culture, or both.
Serana, Thermo Fisher Scientific Inc., GE Healthcare, Sartorius AG, Rockey Mountain Biologicals, Merck KGaA, Atlanta Biologicals, Inc., Corning Inc., PAN-Biotech GmbH, Atlas Biologicals, Inc., Capricorn Scientific, TCS Biosciences Ltd., Novus Biologicals, LLC, and Bovogen Biologicals Pty Ltd. are significant market participants in the newborn calf serum market.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5331
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Newborn Calf Serum Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Newborn Calf Serum Industry Impact
Chapter 2 Global Newborn Calf Serum Competition by Types, Applications, and Top Regions and Countries
2.1 Global Newborn Calf Serum (Volume and Value) by Type
2.3 Global Newborn Calf Serum (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Newborn Calf Serum Sales, Consumption, Export, Import by Regions (2017-2023)
Chapter 5 North America Newborn Calf Serum Market Analysis
Chapter 6 East Asia Newborn Calf Serum Market Analysis
Chapter 7 Europe Newborn Calf Serum Market Analysis
Chapter 8 South Asia Newborn Calf Serum Market Analysis
Chapter 9 Southeast Asia Newborn Calf Serum Market Analysis
Chapter 10 Middle East Newborn Calf Serum Market Analysis
Chapter 11 Africa Newborn Calf Serum Market Analysis
Chapter 12 Oceania Newborn Calf Serum Market Analysis
Chapter 13 South America Newborn Calf Serum Market Analysis
Chapter 14 Company Profiles and Key Figures in Newborn Calf Serum Business
Chapter 15 Global Newborn Calf Serum Market Forecast (2023-2030)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5331
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027